Diagnostic delay and complications for older adults with multiple myeloma

References

• Committee on Quality of Health Care in America. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press, Washington, DC 2001
   Google Scholar
• United Kingdom Department of Health. The NHS Improvement Plan: Putting People at the Heart of Public Services. [Internet]; 24 June 2004 [cited 2008 March 1]. Available from: http://www.dh.gov/uk/publications
   Google Scholar
• To Err is Human: Building a Safer Health System, L T Kohn, J M Corrigan, M S Donaldson. National Academy Press, Washington, DC 2000, http://books.nap.edu/catalog/9728.html
   Google Scholar
• Jiwa M, Reid J, Handley C, Grimwood J, Ward S, Turner K, et al. Less haste more speed: factors that prolong the interval from presentation to diagnosis in some cancers. Fam Pract 2004; 21: 299–303
   PubMed Web of Science ®Google Scholar
• Tabar L, Fagerberg C J, Gad A, Baldetorp L, Holmberg L H, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829–832
   PubMed Web of Science ®Google Scholar
• Arbman G, Nilsson E, Storgren-Fordell V, Sjodahl R. A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg 1996; 162: 899–904
   PubMedGoogle Scholar
• Richards M A, Smith P, Ramirez A J, Fentiman I S, Rubens R D. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999; 79: 858–864
   PubMed Web of Science ®Google Scholar
• Olivotto I A, Gomi A, Bancej C, Brisson J, Tonita J, Kan L, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002; 94: 2143–2150
   PubMed Web of Science ®Google Scholar
• Rossi S, Cinini C, Di Pietro C, Lombardi C P, Crucitti A, Bellantone R, et al. Diagnostic delay in breast cancer: correlation with disease stage and prognosis. Tumori 1990; 76: 559–562
   PubMed Web of Science ®Google Scholar
• Robinson E, Mohilever J, Zidan J, Sapir D. Colorectal cancer: incidence, delay in diagnosis and stage of disease. Eur J Cancer Clin Oncol 1986; 22: 157–161
   PubMedGoogle Scholar
• DerKinderen D J, Koten J W, Van Romunde L K, Nagelkerke N J, Tan K E, Beemer F A, et al. Early diagnosis of bilateral retinoblastoma reduces death and blindness. Int J Cancer 1989; 44: 35–39
   PubMed Web of Science ®Google Scholar
• United Kingdom Department of Health. Faster and fairer access to cancer care – new cancer referral guidelines published. [press release]. [Internet]; 31 March 2001 [cited 29 February 2008] Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Pressreleases/DH_4002515
   Google Scholar
• Hodgson T A, Buchanan J A, Garg A, Ilyas S E, Porter S R. An audit of the UK national cancer referral guidelines for suspected oral mucosal malignancy. Br Dent J 2006; 201: 643–647
   PubMed Web of Science ®Google Scholar
• Mahon C C, Vaizey C J, Taylor I, Boulos P B. Preliminary evaluation of United Kingdom National Referral Guidelines for lower gastrointestinal tract cancer. Colorectal Dis 2002; 4: 111–114
   PubMedGoogle Scholar
• Panter S J, Bramble M G, O'Flanagan H, Hungin A P. Urgent cancer referral guidelines: a retrospective cohort study of referrals for upper gastrointestinal adenocarcinoma. Br J Gen Pract 2004; 54: 611–613
   PubMed Web of Science ®Google Scholar
• Lancaster J L, Sherman I W. Referral guidelines for cancer need closer scrutiny. BMJ 2001; 322: 1491
   PubMed Web of Science ®Google Scholar
• Wender R C. Cancer screening and prevention in primary care. Obstacles for physicians. Cancer 1993; 72: 1093–1099
   PubMed Web of Science ®Google Scholar
• Williams P A, Williams M. Barriers and incentives for primary care physicians in cancer prevention and detection. Cancer 1988; 61: 2382–2390
   PubMed Web of Science ®Google Scholar
• Triezenberg D J, Smith M A, Holmes T M. Cancer screening and detection in family practice: a MIRNET study. J Fam Pract 1995; 40: 27–33
   PubMed Web of Science ®Google Scholar
• Piga A, Graziano F, Zahra G, Cellerino R. Attitudes of non-oncology physicians dealing with cancer patients. A survey based on clinical scenarios in Ancona province, central Italy. Tumori 1996; 82: 423–429
   PubMed Web of Science ®Google Scholar
• Stephenson A, From L, Cohen A, Tipping J. Family physicians' knowledge of malignant melanoma. J Am Acad Dermatol 1997; 37: 953–957
   PubMed Web of Science ®Google Scholar
• Canto M T, Horowitz A M, Drury T F, Goodman H S. Maryland family physicians' knowledge, opinions and practices about oral cancer. Oral Oncol 2002; 38: 416–424
   PubMed Web of Science ®Google Scholar
• Allgar V L, Neal R D. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005; 92: 1959–1970
   PubMed Web of Science ®Google Scholar
• Allgar V L, Neal R D. General practitioners' management of cancer in England: secondary analysis of data from the National Survey of NHS Patients – Cancer. Eur J Cancer Care (Engl) 2005; 14: 409–416
   PubMed Web of Science ®Google Scholar
• Neal R D, Allgar V L. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the ‘National Survey of NHS Patients: Cancer’. Br J Cancer 2005; 92: 1971–1975
   PubMed Web of Science ®Google Scholar
• Abel G A, Friese C R, Magazu L S, Richardson L C, Fernandez M E, De Zengotita J J, et al. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma 2008; 49: 1352–1359
   PubMed Web of Science ®Google Scholar
• Barlogie B, Shaughnessy J, Epstein J, Sanderson R, Anaissie E, Walker R, . Plasma cell myeloma. Williams Hematology7th ed, M Lichtman, E Beutler, T Kipps, U Seligsohn, K Kaushansky, J Prchal, et al. McGraw-Hill, Columbus, OH 2006
   Google Scholar
• Kariyawasan C C, Hughes D A, Jayatillake M M, Mehta A B. Multiple myeloma: causes and consequences of delay in diagnosis. QJM 2007; 100: 635–640
   PubMed Web of Science ®Google Scholar
• Kyle R A, Gertz M A, Witzig T E, Lust J A, Lacy M Q, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21–33
   PubMed Web of Science ®Google Scholar
• Ong F, Hermans J, Noordijk E M, Wijermans P W, Kluin-Nelemans J C. Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms. Ann Hematol 1995; 70: 149–152
   PubMed Web of Science ®Google Scholar
• Warren J L, Klabunde C N, Schrag D, Bach P B, Riley G F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40: IV-3–IV-18
   Web of Science ®Google Scholar
• Zippin C, Lum D, Hankey B F. Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer 1995; 76: 2343–2350
   PubMed Web of Science ®Google Scholar
• Ries L AG, Kosary C L, Hankey B F, Miller B A, Harras A, Edwards B K. SEER cancer statistics review, 1973–1994. National Cancer Institute. NIH Publication. 1997; 97–2789
   Google Scholar
• National Cancer Institute. Number of persons by race and Hispanic ethnicity for SEER participants. [Internet]; 2000 unknown [cited 2006 December 6] Available from: http://seer.cancer.gov/registries/data.html
   Google Scholar
• Klabunde C N, Potosky A L, Legler J M, Warren J L. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258–1267
   PubMed Web of Science ®Google Scholar
• Kind S, Virnig B, McBean A M. SEER-Medicare: defining the date of diagnosis and treatment, [Internet]; 3 December 2007 [cited 1 March 2008] Available from: http://healthservices.cancer.gov/seermedicare/considerations/date.html
   Google Scholar
• Bursac Z, Gauss C H, Williams D K, Hosmer D W. Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine 2008; 3: 17
   PubMedGoogle Scholar
• Hosmer D W, Lemeshow S. Applied logistic regression. John Wiley & Sons, Inc., New York, NY 1989; 307
   Google Scholar
• Karim F, Islam M A, Chowdhury A MR, Johansson E, Diwan V K. Gender differences in delays in diagnosis and treatment of tuberculosis. Health Policy Plan 2007; 22: 329–334
   PubMed Web of Science ®Google Scholar
• Meischke H, Larsen M P, Eisenberg M S. Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval. Am J Emerg Med 1998; 16: 363–366
   PubMed Web of Science ®Google Scholar
• Banks A D, Dracup K. Are there gender differences in the reasons why African Americans delay in seeking medical help for symptoms of an acute myocardial infarction. Ethn Dis 2007; 17: 221–227
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Rathore S S, Wenger N K, Frederick P D, Abramson J L, Barron H V, et al. National Registry of Myocardial Infarction I. Sex and racial differences in the management of acute myocardial infarction, 1994–2002. N Engl J Med 2005; 353: 671–682
   PubMed Web of Science ®Google Scholar
• Risberg T, Sorbye S W, Norum J, Wist E A. Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 1996; 16: 995–999
   PubMed Web of Science ®Google Scholar
• Rosen P J, Wender R C, Kadkhoda H, Kober S L. Measuring the ability of primary-care physicians to diagnose and manage patients with hematologic malignancies. ASH Annual Meeting Abstracts 2007; 110: 3312
   Google Scholar
• National Comprehensive Cancer Network. Clinical practice guideline for multiple myeloma. [Internet]; 14 August 2008 [cited 1 March 2008] Available from: http://www.nccn.org
   Google Scholar
• Richardson P G, Sonneveld P, Schuster M, Irwin D, Stadtmauer E, Facon T, et al. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 2007; 110: 3557–3560
   PubMed Web of Science ®Google Scholar
• Anargyrou K, Dimopoulos M A, Sezer O, Terpos E. Novel anti-myeloma agents and angiogenesis. Leuk Lymphoma 2008; 49: 677–689
   PubMed Web of Science ®Google Scholar
• San-Miguel J, Harousseau J L, Joshua D, Anderson K C. Individualizing treatment of patients with myeloma in the era of novel agents. J Clin Oncol 2008; 26: 2761–2766
   PubMed Web of Science ®Google Scholar